全文获取类型
收费全文 | 24826篇 |
免费 | 866篇 |
国内免费 | 216篇 |
专业分类
耳鼻咽喉 | 59篇 |
儿科学 | 464篇 |
妇产科学 | 103篇 |
基础医学 | 1005篇 |
口腔科学 | 75篇 |
临床医学 | 1908篇 |
内科学 | 7064篇 |
皮肤病学 | 40篇 |
神经病学 | 344篇 |
特种医学 | 545篇 |
外国民族医学 | 2篇 |
外科学 | 12413篇 |
综合类 | 852篇 |
一般理论 | 1篇 |
预防医学 | 276篇 |
眼科学 | 40篇 |
药学 | 404篇 |
9篇 | |
中国医学 | 13篇 |
肿瘤学 | 291篇 |
出版年
2023年 | 1195篇 |
2022年 | 1653篇 |
2021年 | 2215篇 |
2020年 | 2009篇 |
2019年 | 1035篇 |
2018年 | 798篇 |
2017年 | 658篇 |
2016年 | 581篇 |
2015年 | 627篇 |
2014年 | 1999篇 |
2013年 | 1289篇 |
2012年 | 1138篇 |
2011年 | 1145篇 |
2010年 | 1127篇 |
2009年 | 1191篇 |
2008年 | 792篇 |
2007年 | 837篇 |
2006年 | 789篇 |
2005年 | 598篇 |
2004年 | 539篇 |
2003年 | 532篇 |
2002年 | 468篇 |
2001年 | 452篇 |
2000年 | 379篇 |
1999年 | 399篇 |
1998年 | 181篇 |
1997年 | 123篇 |
1996年 | 108篇 |
1995年 | 97篇 |
1994年 | 86篇 |
1993年 | 75篇 |
1992年 | 128篇 |
1991年 | 112篇 |
1990年 | 110篇 |
1989年 | 88篇 |
1988年 | 82篇 |
1987年 | 26篇 |
1986年 | 15篇 |
1985年 | 28篇 |
1984年 | 39篇 |
1983年 | 13篇 |
1982年 | 26篇 |
1981年 | 11篇 |
1980年 | 14篇 |
1979年 | 9篇 |
1978年 | 15篇 |
1977年 | 9篇 |
1976年 | 15篇 |
1974年 | 8篇 |
1973年 | 14篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
92.
93.
94.
95.
A. Montalto V. Piazza F. Albi R. Gherli C. Contento A. Palermo F. Musumeci 《Transplantation proceedings》2019,51(1):206-209
Background
Pump speed optimization in patients implanted with a ventricular assist device represents a major challenge during the follow-up period. We present our findings on whether combined invasive hemodynamic ramp tests and cardiopulmonary exercise testing (CPX) can help optimize patient management.Methods
Eighteen patients implanted with a HeartMate 3 (HM3) device underwent ramp tests with right heart catheterization (including central venous pressure [CVP], pulmonary artery pressure, pulmonary capillary wedge pressure [PCWP], and blood pressure) and echocardiography. Data were recorded at up to 4 speed settings. Speed changes were in steps of 200 revolutions/min (rpm). Evaluation of functional capacity by CPX was conducted according to the modified Bruce protocol.Results
Only 30% of patients had normal PCWPs at their original rpm settings. In going from lowest to highest speeds, cardiac output improved by 0.25 ± 0.35 L/min/step (total change, 1.28 ± 0.3 L/min), and PCWP decreased by 1.9 ± 0.73 mm Hg/step (total change, 6 ± 1.6 mm Hg). CVP and systolic blood pressure did not change significantly with rpm. The rpm assessment was adjusted based on test results to achieve CVPs and PCWPs as close to normal limits as possible, which was feasible in all patients. On CPX, all patients demonstrated good performance (peak VO2, 16.8 ± 3.5 mL/kg/min).Conclusion
Hemodynamic ramp testing provides an objective means of optimizing rpm, and has the potential to provide good exercise tolerance. 相似文献96.
《Transplantation proceedings》2022,54(4):1124-1126
BackgroundThe aim of the study was to assessment serologic status of Epstein-Barr virus (EBV) infections in patients qualificated for lung transplantation in the first half of 2021.MethodsThe study included 72 patients qualified for lung transplantation from January to June 2021. The youngest patient was aged 14 years and the oldest was aged 65 years. The study group consisted of 36 women and 36 men. In the serum of patients, a multi-parameter, comprehensive diagnosis of EBV infections was performed using the IIFT BIOCHIP EBV sequence tests. This test is based on a combination of several substrates, enabling the simultaneous evaluation of antibodies against capsid antigens (anti-CA antibodies), both in the IgG and IgM class, early antigens (anti-EA), nuclear antigens and the assessment of the avidity of anti-CA antibodies. The analysis of all diagnostically significant antibodies specific for EBV infections, including the avidity of anti-CA antibodies, increases the diagnostic accuracy in differentiating active and past infection with EBV.ResultsIn the studied group it was shown that 58 had past EBV infection (80.6%). Twelve patients (16.6%) have anti-EA antibodies, which indicate that the virus is reactivated. Only 2 patients (2.8%) had no antibodies to EBV.ConclusionsComprehensive assessment of antibodies against various EBV antigens in patients qualified for lung transplantation is important in the management and further diagnosis of this infection, especially after transplantation, due to the risk of developing post-transplant lymphoproliferative disease. 相似文献
97.
98.
99.
100.
《The Canadian journal of cardiology》2019,35(12):1834-1841
BackgroundThe severity score of Ebstein anomaly (EA) that corresponds to clinical status is still under research, with the Celermajer index (Cel-ind) being one of those. The agreement between echocardiographic and cardiac magnetic resonance (CMR) assessment of Cel-ind is not known. We determined the agreement between echocardiography- and CMR-derived Cel-ind and its relationship with heart failure markers.MethodsA total of 37 unoperated adults with EA (mean age, 43.0 ± 14.4 years) underwent echocardiography, CMR, and cardiopulmonary tests. For the Cel-ind, end-diastolic areas in echocardiography or end-diastolic volumes in CMR were used according to the following formula: Cel-ind = (right atrium + atrialized right ventricle)/(functional right ventricle + left atrium + left ventricle). On the basis of this assumption, patients were classified as follows: grade 1 = Cel-ind < 0.5, grade 2 = 0.5 to 0.99, grade 3 = 1.0 to 1.49, grade 4 > 1.5. The agreement between echocardiographic and CMR was determined with the intraclass correlation coefficient or Cohen’s kappa (<0.2 poor agreement; 0.2-0.4 fair agreement; 0.4-0.6 moderate agreement; 0.6-0.8 good agreement; 0.8-1.0 very good agreement).ResultsThe median echoCel-ind was 0.9 (range, 0.4-2.3), and the median cmrCel-ind was 0.7 (range, 0.3-5.3). Grade 1 or 2 was found in 19 patients (51.3%) by echocardiography and in 27 patients (72.9%) by CMR. The agreement between imaging methods was only fair (kappa = 0.39, P = 0.002) for the 4-grade classification and moderate (intra-class correlation coefficient = 0.43; 95% confidence interval, 0.13-0.66) for Cel-ind calculation. Significant correlations between Cel-ind in CMR and cardiopulmonary parameters were found (for peak oxygen uptake: R = −0.35, P = 0.034; for the ventilation/carbon dioxide slope: R = 0.46, P = 0.005). Neither of them correlated with echocardiographic severity score.ConclusionsThe agreement between echocardiographic and CMR assessment of the Cel-ind is at most moderate; echocardiography usually overestimates, but rarely underestimates, EA severity. Cel-ind by CMR seems to be more valuable, because it is associated with heart failure markers. 相似文献